GetTopicDetailResponse(id=d85242655e3, topicName=復(fù)方苦參注射液, introduction=復(fù)方苦參注射液, content=null, image=null, comments=1, allHits=1735, url=https://h5.medsci.cn/topic?id=42655, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=37997, tagList=[TagDto(tagId=37997, tagName=復(fù)方苦參注射液)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=813598, encodeId=efe0813598c7, content=中藥<a href='/topic/show?id=d85242655e3' target=_blank style='color:#2F92EE;'>#復(fù)方苦參注射液#</a>通過(guò)TNFR1解除腫瘤免疫<a href='/topic/show?id=430750648d8' target=_blank style='color:#2F92EE;'>#微環(huán)境#</a>中的腫瘤相關(guān)巨噬細(xì)胞（TAMs）引起的免疫抑制，, objectTitle=J Immunother Cancer：營(yíng)養(yǎng)與健康所等揭示中藥復(fù)方苦參注射液增敏索拉菲尼治療肝癌新機(jī)制, objectType=article, longId=191141, objectId=07ec191141e3, topicUrl=null, isHasObj=0, objectCover=, objectUrl=/article/show_article.do?id=07ec191141e3, replyNumber=0, likeNumber=274, createdTime=2020-08-26, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=07ec191141e3, moduleTitle=J Immunother Cancer：營(yíng)養(yǎng)與健康所等揭示中藥復(fù)方苦參注射液增敏索拉菲尼治療肝癌新機(jī)制, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=07ec191141e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
